Phadke O. et al [13] described a case series of 3 patients with sJIA/MAS who underwent IL-1 A or IL-6 A treatment, with two patients developing biopsy proven hepatitis less than a month into follow-up of anakinra. This evidence concerns the gene IL1B and Hepatitis.